Oncoinfo路 @Oncoinfo_it 路 X路路 14 hours agoScore70
Body
#ESMO26 | Armando Orlandi commenta i risultati dello studio TALENT su T-DXd nelle pazienti con carcinoma mammario HR+/HER2-low in fase neoadiuvante馃憞
#OncoSTEPS #earlybreastcancer #eBC
40 views 路 0 likes 路 0 reposts 路 0 replies
Conference abstracts
LBA23matched by Proffered paper 1: Breast cancer, early and advanced stage
Final results of TALENT: A neoadjuvant trial of T-DXd with or without anastrozole, or in sequence with chemotherapy for HER2-low, HR+ early-stage breast cancer
https://esmocongress.esmo.orgSource: Oncoinfo 路 x.com